Key Record Dates
ClinicalTrials.gov Identifier: | NCT03012620 |
---|---|
Brief Title: | Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types (AcSé) |
First Submitted : | January 2, 2017 |
First Submitted that Met QC Criteria : | January 4, 2017 |
First Posted : | January 6, 2017 (Estimate) |
Last Update Submitted that Met QC Criteria : | December 11, 2020 |
Last Update Posted : | December 16, 2020 |